Top Markets
#1 ADO Protocol ADO Protocol +195.10%
#2 Islamic Coin Islamic Coin +155.35%
#3 GoPlus Security GoPlus Security +54.44%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +22.00%
#6 Verus Coin Verus Coin +13.54%
#7 Tutorial Tutorial +12.72%
#8 Casper Network Casper Network +12.03%
#9 SkyAI SkyAI +11.78%
#10 Pons Pons +11.75%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Kedudukan dalam Saham #33642
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Harga Saham
$0.03702159
Disegerakkan terakhir: 2024-01-29
Modal Pasaran
$7.21M
Perubahan (1 hari)
-3.08%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan Antisense Therapeutics Limited (ANP)

Kategori

Healthcare
Pendapatan untuk Antisense Therapeutics Limited (ANP)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Antisense Therapeutics Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Antisense Therapeutics Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN